We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Monoamine oxidase inhibition improves vascular function in mammary arteries from nondiabetic and diabetic patients with coronary heart disease<sup>1</sup>.
- Authors
Lighezan, Rodica; Sturza, Adrian; Duicu, Oana M.; Ceausu, Raluca A.; Vaduva, Adrian; Gaspar, Marian; Feier, Horea; Vaida, Monica; Ivan, Viviana; Lighezan, Daniel; Muntean, Danina M.; Mornos, Cristian
- Abstract
Monoamine oxidases (MAOs) are mitochondrial enzymes with 2 isoforms that have emerged as important contributors to cardiovascular oxidative stress via the constant generation of hydrogen peroxide. The present study was purported to assess whether MAO-derived H2O2 contributes to the endothelial dysfunction in mammary arteries harvested from coronary heart disease patients with and without diabetes mellitus subjected to coronary artery bypass grafting. To this aim, the effects of MAO inhibition on vascular contractility to phenylephrine and endothelial-dependent relaxation (EDR) in response to acetylcholine were studied in vascular segments. Clorgyline (irreversible MAO-A inhibitor), selegiline (irreversible MAO-B inhibitor), and moclobemide (reversible MAO-A inhibitor) were applied in the organ bath (10 μmol/L). MAO expression was assessed by immunohistochemistry. We found a constant impairment of EDR that has been significantly attenuated in the presence of the MAO-A and MAO-B inhibitors in both groups of coronary heart disease patients. MAO-B was the dominant isoform in all human diseased vessels. In conclusion, in vitro inhibition of MAO significantly improved EDR in human mammary arteries, regardless of the presence of diabetes. These data suggest that MAO inhibitors might be useful in restoring endothelial response in clinical conditions associated with increased oxidative stress, such as coronary artery disease and diabetes.
- Subjects
MONOAMINE oxidase inhibitors; CORONARY disease; HYDROGEN peroxide; ENDOTHELIUM diseases; SELEGILINE; IMMUNOHISTOCHEMISTRY
- Publication
Canadian Journal of Physiology & Pharmacology, 2016, Vol 94, Issue 10, p1040
- ISSN
0008-4212
- Publication type
Article
- DOI
10.1139/cjpp-2015-0580